Ipr Drug Patent Portfolio
Ipr owns 1 orange book drug protected by 4 US patents Given below is the list of Ipr's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5466699 | Indolyl compounds for treating migraine | 14 May, 2013 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 May, 2013 | Expired |
| US5466699 | Indolyl compounds for treating migraine | 14 Nov, 2012 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 Nov, 2012 | Expired |
Latest Legal Activities on Ipr's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ipr.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Nov, 2018 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 02 Feb, 2016 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 27 Jan, 2016 | US6750237 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 May, 2007 | US7220767 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 22 May, 2007 | US7220767 (Litigated) |
|
Issue Notification Mailed
Critical
| 02 May, 2007 | US7220767 (Litigated) |
| Dispatch to FDC | 19 Apr, 2007 | US7220767 (Litigated) |
|
Issue Fee Payment Received
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
| Mail Corrected Notice of Allowance | 23 Jan, 2007 | US7220767 (Litigated) |
| Corrected Notice of Allowance | 19 Jan, 2007 | US7220767 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 31 Jul, 2006 | US6750237 (Litigated) |
|
Correspondence Address Change
Critical
| 31 Jul, 2006 | US6750237 (Litigated) |
|
Mail Notice of Allowance
Critical
| 14 Mar, 2006 | US7220767 (Litigated) |
Ipr's Family Patents
Ipr Drug List
Given below is the complete list of Ipr's drugs and the patents protecting them.
1. Zomig
Zomig is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5466699
(Pediatric)
| Indolyl compounds for treating migraine |
14 May, 2013
(12 years ago)
| Expired |
| US5863935
(Pediatric)
| Therapeutic heterocyclic compounds |
14 May, 2013
(12 years ago)
| Expired |
| US5466699 | Indolyl compounds for treating migraine |
14 Nov, 2012
(13 years ago)
| Expired |
| US5863935 | Therapeutic heterocyclic compounds |
14 Nov, 2012
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zomig's drug page